Correlation Between Oncopeptides and Active Biotech
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Active Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Active Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Active Biotech AB, you can compare the effects of market volatilities on Oncopeptides and Active Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Active Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Active Biotech.
Diversification Opportunities for Oncopeptides and Active Biotech
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Oncopeptides and Active is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Active Biotech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Active Biotech AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Active Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Active Biotech AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and Active Biotech go up and down completely randomly.
Pair Corralation between Oncopeptides and Active Biotech
Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Active Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Oncopeptides AB is 3.58 times less risky than Active Biotech. The stock trades about -0.16 of its potential returns per unit of risk. The Active Biotech AB is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 19.00 in Active Biotech AB on September 1, 2024 and sell it today you would earn a total of 8.00 from holding Active Biotech AB or generate 42.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncopeptides AB vs. Active Biotech AB
Performance |
| Timeline |
| Oncopeptides AB |
| Active Biotech AB |
Oncopeptides and Active Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncopeptides and Active Biotech
The main advantage of trading using opposite Oncopeptides and Active Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Active Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Active Biotech will offset losses from the drop in Active Biotech's long position.| Oncopeptides vs. Hansa Biopharma AB | Oncopeptides vs. BioArctic AB | Oncopeptides vs. Sinch AB | Oncopeptides vs. Cantargia AB |
| Active Biotech vs. Cantargia AB | Active Biotech vs. BioArctic AB | Active Biotech vs. Oncopeptides AB | Active Biotech vs. Hansa Biopharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |